BTSDF vs PEP: Which Stock is Better?
Side-by-side comparison of Health and Happiness (H&H) International Holdings Limited and Pepsico Inc in 2026
BTSDF
Health and Happiness (H&H) International Holdings Limited
$1.59
PEP
Pepsico Inc
$147.66
Key Metrics Comparison
| Metric | BTSDF | PEP | Winner |
|---|---|---|---|
| Market Cap | $968.34M | $200.32B | PEP |
| P/E Ratio | N/A | 27.87 | PEP |
| EPS (TTM) | $N/A | $5.25 | PEP |
| Revenue Growth | 0.0% | 0.0% | BTSDF |
| Gross Margin | 61.5% | 54.3% | BTSDF |
Analyze BTSDF
Full quant analysis
Analyze PEP
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is BTSDF or PEP a better investment?
Comparing BTSDF and PEP: Health and Happiness (H&H) International Holdings Limited has a market cap of $968.34M while Pepsico Inc has $200.32B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between BTSDF and PEP?
BTSDF (Health and Happiness (H&H) International Holdings Limited) and PEP (Pepsico Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: BTSDF or PEP?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: BTSDF or PEP?
BTSDF has higher revenue growth at 0.0% vs 0.0% for PEP.
Which company is more profitable: BTSDF or PEP?
Health and Happiness (H&H) International Holdings Limited (BTSDF) has higher gross margins at 61.5% compared to 54.3% for PEP.
Which is the larger company: BTSDF or PEP?
Pepsico Inc (PEP) is larger with a market cap of $200.32B compared to $968.34M for BTSDF.
Should I buy BTSDF or PEP in 2026?
Both BTSDF and PEP have investment merit. BTSDF trades at $1.59 while PEP trades at $147.66. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between BTSDF and PEP stock?
Key differences: Market Cap ($968.34M vs $200.32B), P/E Ratio (N/A vs 27.9x), Revenue Growth (0.0% vs 0.0%), Gross Margin (61.5% vs 54.3%).